Warburg and Advent in the lead to acquire Baxter’s biopharma unit-sources

NEW YORK — A private equity consortium comprising Warburg Pincus and Advent International is in advanced talks to acquire medical device maker Baxter International Inc’s biopharma solutions business in a deal that could reach or exceed $4 billion, people familiar with the matter said on Sunday…
Read More

Get A FREE Copy Of My Special Report
“Can Your Retirement Survive” Today!
There's Absolutely $0 Cost To You!
We Even Pay For Shipping & Handling!

This post contains affiliate links. If you use these links to buy something we may earn a commission. Thanks.”

You May Also Like